AVR anteris technologies global corp.

Clinical trials, page-16

  1. 2,285 Posts.
    lightbulb Created with Sketch. 842
    If we are on our game we would be on the front foot getting in contact with Bain Capital and at least another half a dozen investors that backed Jenavalve.
    They may be looking for somewhere to park a few hundred million from their realised investment.
    Would be nice to have backup and an alternative to the NASDAQ, or adding some pent up demand for the IPO by investors that obviously understand the space.

    In 2022 Jenavalve raised US$100m to complete their pivotal trial through these investors.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.69
Change
0.190(3.45%)
Mkt cap ! $86.68M
Open High Low Value Volume
$5.29 $5.69 $5.29 $78.92K 14.44K

Buyers (Bids)

No. Vol. Price($)
2 972 $5.50
 

Sellers (Offers)

Price($) Vol. No.
$5.68 3152 1
View Market Depth
Last trade - 12.39pm 07/08/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.